Revance Therapeutics pushes Botox 'breakup' in latest campaign for rival cosmetic drug
Revance Therapeutics has used ChatGPT in an effort to convince users to “break up with Botox” for the treatment of frown lines in favor of its rival drug Daxxify.
The campaign launched last Tuesday with a 30-second “breakup song,” as well as two videos featuring women practicing their Botox breakup in the mirror. While Revance’s Daxxify is never mentioned in the jingle or videos, a button at the bottom of the campaign’s website captioned, “Meet your new boo,” links to the drug’s website.
Unlock this article instantly by becoming a free subscriber.
You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.